Is osteoporosis a peculiar association with primary biliary cirrhosis
AIM: (1) To compare the prevalence of osteoporosis (t-score ≤-2.5 SD) between stage IV PBC patients, and two groups of age- and sex-matched controls: one with hepatitis C virus (HCV)-related cirrhosis, and the other one consisting of a group of healthy subjects from the general population, (2) to id...
Saved in:
Published in | World journal of gastroenterology : WJG Vol. 11; no. 34; pp. 5347 - 5350 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
United States
Department of Surgical and Gastroenterological Sciences, University of Padova,Italy%Department of Medical and Surgical Sciences, University of Padova, Italy%Department of Public Health, University of Padova, Italy%Department of Clinical Chemistry, University of Padova, Italy
14.09.2005
Baishideng Publishing Group Inc |
Subjects | |
Online Access | Get full text |
ISSN | 1007-9327 2219-2840 |
DOI | 10.3748/wjg.v11.i34.5347 |
Cover
Loading…
Abstract | AIM: (1) To compare the prevalence of osteoporosis (t-score ≤-2.5 SD) between stage IV PBC patients, and two groups of age- and sex-matched controls: one with hepatitis C virus (HCV)-related cirrhosis, and the other one consisting of a group of healthy subjects from the general population, (2) to identify the main risk factors for the development of bone loss.
METHODS: Thirty-five stage IV PBC patients (mean age 52.5±10 years), 49 females with HCV-related cirrhosis (mean age 52.9±5.8 years) and 33 healthy females (mean age 51.8±2.22 years) were enrolled in the study. Bone metabolism was evaluated by measuring serum calcium corrected for serum albumin (Ca corr.), 25-hydroxy vitamin D (25-OH vit D), parathyroid hormone, osteocaldn. Bone mineral density (BMD) was assessed at the lumbar spine by dual-photon X-ray absorptiometry. RESULTS: Osteoporosis was present in 5/35 PBC patients (14.2%) and in 7/49 HCV-related drrhotic patients (14.3%), without any statistical difference between the two groups. Among healthy control subjects, none had osteoporosis. No difference was found between the three groups in serum parameters of bone metabolism. Univariate analysis showed that menopausal state and low BMI were significantly correlated with osteoporosis. Multivariate regression analysis showed that menopausal status, BMI〈23, and old age were independent variables significantly correlated with osteoporosis. CONCLUSION: PBC in itself has no negative influence on BMD. End-stage liver disease patients carry a disease-specific risk for osteoporosis, but have an effective risk of bone loss in relation to individual potential risk for each patient. A practical message should be taken into account, that is, every effort should be made to prevent osteoporosis when a patient has simple osteopenia, or if it is a woman in or near menopausal age. |
---|---|
AbstractList | (1) To compare the prevalence of osteoporosis (t-score < or =-2.5 SD) between stage IV PBC patients, and two groups of age- and sex-matched controls: one with hepatitis C virus (HCV)-related cirrhosis, and the other one consisting of a group of healthy subjects from the general population; (2) to identify the main risk factors for the development of bone loss.
Thirty-five stage IV PBC patients (mean age 52.5+/-10 years), 49 females with HCV-related cirrhosis (mean age 52.9+/-5.8 years) and 33 healthy females (mean age 51.8+/-2.22 years) were enrolled in the study. Bone metabolism was evaluated by measuring serum calcium corrected for serum albumin (Ca corr.), 25-hydroxy vitamin D (25-OH vit D), parathyroid hormone, osteocalcin. Bone mineral density (BMD) was assessed at the lumbar spine by dual-photon X-ray absorptiometry.
Osteoporosis was present in 5/35 PBC patients (14.2%) and in 7/49 HCV-related cirrhotic patients (14.3%), without any statistical difference between the two groups. Among healthy control subjects, none had osteoporosis. No difference was found between the three groups in serum parameters of bone metabolism. Univariate analysis showed that menopausal state and low BMI were significantly correlated with osteoporosis. Multivariate regression analysis showed that menopausal status, BMI <23, and old age were independent variables significantly correlated with osteoporosis.
PBC in itself has no negative influence on BMD. End-stage liver disease patients carry a disease-specific risk for osteoporosis, but have an effective risk of bone loss in relation to individual potential risk for each patient. A practical message should be taken into account, that is, every effort should be made to prevent osteoporosis when a patient has simple osteopenia, or if it is a woman in or near menopausal age. AIM: (1) To compare the prevalence of osteoporosis (t-score ≤-2.5 SD) between stage IV PBC patients, and two groups of age- and sex-matched controls: one with hepatitis C virus (HCV)-related cirrhosis, and the other one consisting of a group of healthy subjects from the general population, (2) to identify the main risk factors for the development of bone loss. METHODS: Thirty-five stage IV PBC patients (mean age 52.5±10 years), 49 females with HCV-related cirrhosis (mean age 52.9±5.8 years) and 33 healthy females (mean age 51.8±2.22 years) were enrolled in the study. Bone metabolism was evaluated by measuring serum calcium corrected for serum albumin (Ca corr.), 25-hydroxy vitamin D (25-OH vit D), parathyroid hormone, osteocaldn. Bone mineral density (BMD) was assessed at the lumbar spine by dual-photon X-ray absorptiometry. RESULTS: Osteoporosis was present in 5/35 PBC patients (14.2%) and in 7/49 HCV-related drrhotic patients (14.3%), without any statistical difference between the two groups. Among healthy control subjects, none had osteoporosis. No difference was found between the three groups in serum parameters of bone metabolism. Univariate analysis showed that menopausal state and low BMI were significantly correlated with osteoporosis. Multivariate regression analysis showed that menopausal status, BMI〈23, and old age were independent variables significantly correlated with osteoporosis. CONCLUSION: PBC in itself has no negative influence on BMD. End-stage liver disease patients carry a disease-specific risk for osteoporosis, but have an effective risk of bone loss in relation to individual potential risk for each patient. A practical message should be taken into account, that is, every effort should be made to prevent osteoporosis when a patient has simple osteopenia, or if it is a woman in or near menopausal age. (1) To compare the prevalence of osteoporosis (t-score < or =-2.5 SD) between stage IV PBC patients, and two groups of age- and sex-matched controls: one with hepatitis C virus (HCV)-related cirrhosis, and the other one consisting of a group of healthy subjects from the general population; (2) to identify the main risk factors for the development of bone loss.AIM(1) To compare the prevalence of osteoporosis (t-score < or =-2.5 SD) between stage IV PBC patients, and two groups of age- and sex-matched controls: one with hepatitis C virus (HCV)-related cirrhosis, and the other one consisting of a group of healthy subjects from the general population; (2) to identify the main risk factors for the development of bone loss.Thirty-five stage IV PBC patients (mean age 52.5+/-10 years), 49 females with HCV-related cirrhosis (mean age 52.9+/-5.8 years) and 33 healthy females (mean age 51.8+/-2.22 years) were enrolled in the study. Bone metabolism was evaluated by measuring serum calcium corrected for serum albumin (Ca corr.), 25-hydroxy vitamin D (25-OH vit D), parathyroid hormone, osteocalcin. Bone mineral density (BMD) was assessed at the lumbar spine by dual-photon X-ray absorptiometry.METHODSThirty-five stage IV PBC patients (mean age 52.5+/-10 years), 49 females with HCV-related cirrhosis (mean age 52.9+/-5.8 years) and 33 healthy females (mean age 51.8+/-2.22 years) were enrolled in the study. Bone metabolism was evaluated by measuring serum calcium corrected for serum albumin (Ca corr.), 25-hydroxy vitamin D (25-OH vit D), parathyroid hormone, osteocalcin. Bone mineral density (BMD) was assessed at the lumbar spine by dual-photon X-ray absorptiometry.Osteoporosis was present in 5/35 PBC patients (14.2%) and in 7/49 HCV-related cirrhotic patients (14.3%), without any statistical difference between the two groups. Among healthy control subjects, none had osteoporosis. No difference was found between the three groups in serum parameters of bone metabolism. Univariate analysis showed that menopausal state and low BMI were significantly correlated with osteoporosis. Multivariate regression analysis showed that menopausal status, BMI <23, and old age were independent variables significantly correlated with osteoporosis.RESULTSOsteoporosis was present in 5/35 PBC patients (14.2%) and in 7/49 HCV-related cirrhotic patients (14.3%), without any statistical difference between the two groups. Among healthy control subjects, none had osteoporosis. No difference was found between the three groups in serum parameters of bone metabolism. Univariate analysis showed that menopausal state and low BMI were significantly correlated with osteoporosis. Multivariate regression analysis showed that menopausal status, BMI <23, and old age were independent variables significantly correlated with osteoporosis.PBC in itself has no negative influence on BMD. End-stage liver disease patients carry a disease-specific risk for osteoporosis, but have an effective risk of bone loss in relation to individual potential risk for each patient. A practical message should be taken into account, that is, every effort should be made to prevent osteoporosis when a patient has simple osteopenia, or if it is a woman in or near menopausal age.CONCLUSIONPBC in itself has no negative influence on BMD. End-stage liver disease patients carry a disease-specific risk for osteoporosis, but have an effective risk of bone loss in relation to individual potential risk for each patient. A practical message should be taken into account, that is, every effort should be made to prevent osteoporosis when a patient has simple osteopenia, or if it is a woman in or near menopausal age. AIM: (1) To compare the prevalence of osteoporosis ( t -score ≤ -2.5 SD) between stage IV PBC patients, and two groups of age- and sex-matched controls: one with hepatitis C virus (HCV)-related cirrhosis, and the other one consisting of a group of healthy subjects from the general population; (2) to identify the main risk factors for the development of bone loss. METHODS: Thirty-five stage IV PBC patients (mean age 52.5 ± 10 years), 49 females with HCV-related cirrhosis (mean age 52.9 ± 5.8 years) and 33 healthy females (mean age 51.8 ± 2.22 years) were enrolled in the study. Bone metabolism was evaluated by measuring serum calcium corrected for serum albumin (Ca corr.), 25-hydroxy vitamin D (25-OH vit D), parathyroid hormone, osteocalcin. Bone mineral density (BMD) was assessed at the lumbar spine by dual-photon X-ray absorptiometry. RESULTS: Osteoporosis was present in 5/35 PBC patients (14.2%) and in 7/49 HCV-related cirrhotic patients (14.3%), without any statistical difference between the two groups. Among healthy control subjects, none had osteoporosis. No difference was found between the three groups in serum parameters of bone metabolism. Univariate analysis showed that menopausal state and low BMI were significantly correlated with osteoporosis. Multivariate regression analysis showed that menopausal status, BMI < 23, and old age were independent variables significantly correlated with osteoporosis. CONCLUSION: PBC in itself has no negative influence on BMD. End-stage liver disease patients carry a disease-specific risk for osteoporosis, but have an effective risk of bone loss in relation to individual potential risk for each patient. A practical message should be taken into account, that is, every effort should be made to prevent osteoporosis when a patient has simple osteopenia, or if it is a woman in or near menopausal age. R5; AIM: (1) To compare the prevalence of osteoporosis (t-score ≤-2.5 SD) between stage Ⅳ PBC patients, and two groups of age- and sex-matched controls: one with hepatitis C virus (HCV)-related cirrhosis, and the other one consisting of a group of healthy subjects from the general population; (2) to identify the main risk factors for the development of bone loss.METHODS: Thirty-five stage Ⅳ PBC patients (mean age 52.5±10 years), 49 females with HCV-related cirrhosis (mean age 52.9±5.8 years) and 33 healthy females (mean age 51.8+2.22 years) were enrolled in the study. Bone metabolism was evaluated by measuring serum calcium corrected for serum albumin (Ca corr.), 25-hydroxy vitamin D (25-OH vit D), parathyroid hormone, osteocalcin.Bone mineral density (BMD) was assessed at the lumbar spine by dual-photon X-ray absorptiometry.RESULTS: Osteoporosis was present in 5/35 PBC patients (14.2%) and in 7/49 HCV-related cirrhotic patients (14.3%),without any statistical difference between the two groups.Among healthy control subjects, none had osteoporosis.No difference was found between the three groups in serum parameters of bone metabolism. Univariate analysis showed that menopausal state and low BMI were significantly correlated with osteoporosis. Multivariate regression analysis showed that menopausal status, BMI <23, and old age were independent variables significantly correlated with osteoporosis.CONCLUSION: PBC in itself has no negative influence on BMD. End-stage liver disease patients carry a disease-specific risk for osteoporosis, but have an effective risk of bone loss in relation to individual potential risk for each patient. A practical message should be taken into account, that is, every effort should be made to prevent osteoporosis when a patient has simple osteopenia, or if it is a woman in or near menopausal age. |
Author | Annarosa Floreani Andrea Mega Valentina Camozzi Vincenzo Baldo Mario Plebani Patrizia Burra Giovanni Luise Luisetto |
AuthorAffiliation | Department of Surgical and Gastroenterological Sciences, University of Padova,Italy Department of Medicaland Surgical Sciences, University of Padova, Italy Department of Public Health, University of Padova, Italy Department of Clinical Chemistry, University of Padova, Italy |
AuthorAffiliation_xml | – name: Department of Surgical and Gastroenterological Sciences, University of Padova,Italy%Department of Medical and Surgical Sciences, University of Padova, Italy%Department of Public Health, University of Padova, Italy%Department of Clinical Chemistry, University of Padova, Italy |
Author_xml | – sequence: 1 givenname: Annarosa surname: Floreani fullname: Floreani, Annarosa |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/16149144$$D View this record in MEDLINE/PubMed |
BookMark | eNp9UcFu1DAUtFAR3ZbeOaEIIW5Znu2XxL4gVVWBSpW4wNlyHGfXS9be2klX_XscdqEtB07v8GbmzZs5Iyc-eEvIGwpL3qD4uN-slveULh3HZcWxeUEWjFFZMoFwQhYUoCklZ80pOUtpA8A4r9grckpripIiLsj1TSpCGm3YhRiSS4UudtZMg9Ox0CkF4_Togi_2blwXu-i2Oj4UrZv3D4VxMa5n1mvystdDshfHeU5-fL7-fvW1vP325ebq8rY0WMFYdqzthLRYoZCyl9y0ViITHc0ejUTgTdt1tOo19hyZrSqwiLzTum1BQ9_wc_LpoLub2q3tjPVj1IM6-lJBO_V8491arcK9wpoxAbPA-4PAXvte-5XahCn6bFnlKBlADhFonWEfjndiuJtsGtXWJWOHQXsbpqRqUdVM8Fnv7VNDf538CTgD4AAwOd4Ubf8IATV3OB9WuUOVO1Rzh5lS_0MxbvzdQn7JDf8jvjsS18Gv7lx-r9XmZ-8GqxggF3XN-C-vTq8c |
CitedBy_id | crossref_primary_10_1007_s00774_007_0833_1 crossref_primary_10_1111_jgh_13062 crossref_primary_10_1371_journal_pone_0194418 crossref_primary_10_1016_j_cgh_2006_10_015 crossref_primary_10_1097_MCG_0b013e318032388d crossref_primary_10_3748_wjg_v12_i22_3537 crossref_primary_10_2165_00024677_200605050_00004 crossref_primary_10_1002_hep_26696 crossref_primary_10_1016_j_cgh_2009_01_011 crossref_primary_10_3390_nu8060319 crossref_primary_10_3748_wjg_v29_i29_4580 crossref_primary_10_1007_s10067_017_3844_x crossref_primary_10_1007_s12519_017_0013_x crossref_primary_10_1002_iid3_1258 crossref_primary_10_1016_j_transproceed_2007_06_093 |
Cites_doi | 10.1053/jhep.2001.20533 10.1016/s0168-8278(01)81646-9 10.1016/S1297-319X(02)00364-0 10.1016/S0168-8278(99)80167-6 10.1016/S0168-8278(01)00144-1 10.1016/S0016-5085(03)01060-6 10.1159/000171456 10.1016/S0016-5085(00)70423-9 10.1136/gut.31.1.82 10.1002/lt.500040413 10.7326/0003-4819-103-6-855 10.1210/jcem-69-6-1234 10.1136/gut.49.2.282 10.1136/bmj.310.6991.1357 10.1172/JCI117959 10.1002/hep.1840210138 10.1002/jbmr.5650111203 10.1016/S0168-8278(03)00143-0 10.1016/S1590-8658(03)00078-1 |
ClassificationCodes | R5 |
ContentType | Journal Article |
Copyright | Copyright © Wanfang Data Co. Ltd. All Rights Reserved. The Author(s) 2005. Published by Baishideng Publishing Group Inc. All rights reserved. 2005 |
Copyright_xml | – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved. – notice: The Author(s) 2005. Published by Baishideng Publishing Group Inc. All rights reserved. 2005 |
DBID | 2RA 92L CQIGP W91 ~WA AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 2B. 4A8 92I 93N PSX TCJ 5PM |
DOI | 10.3748/wjg.v11.i34.5347 |
DatabaseName | 维普期刊资源整合服务平台 中文科技期刊数据库-CALIS站点 中文科技期刊数据库-7.0平台 中文科技期刊数据库-医药卫生 中文科技期刊数据库- 镜像站点 CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Wanfang Data Journals - Hong Kong WANFANG Data Centre Wanfang Data Journals 万方数据期刊 - 香港版 China Online Journals (COJ) China Online Journals (COJ) PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
DocumentTitleAlternate | Is osteoporosis a peculiar association with primary biliary cirrhosis |
EISSN | 2219-2840 |
EndPage | 5350 |
ExternalDocumentID | PMC4622807 wjg200534016 16149144 10_3748_wjg_v11_i34_5347 20438662 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: 教育部高等院校资助项目 |
GroupedDBID | --- 123 29R 2B. 2C~ 2RA 2WC 36B 53G 5VR 8WL 92F 92I 92L 93N 93R AAKDD ACGFO AENEX AFUIB ALMA_UNASSIGNED_HOLDINGS CCEZO CDYEO CHBEP CIEJG CQIGP CS3 CW9 DIK DU5 E3Z EBS EJD EMB F5P FA0 FRP GX1 HYE M~E OK1 P2P RNS RPM SV3 TCJ TGQ TR2 W91 WFFXF XSB ~WA AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 4A8 PSX 5PM |
ID | FETCH-LOGICAL-c450t-d2bd89e454899f93cbe9428d1932c94037bdd15fa4f342e550e443daabb0a0f73 |
ISSN | 1007-9327 |
IngestDate | Thu Aug 21 18:13:41 EDT 2025 Thu May 29 04:01:26 EDT 2025 Fri Jul 11 08:40:37 EDT 2025 Wed Oct 16 00:47:23 EDT 2024 Tue Jul 01 01:54:00 EDT 2025 Thu Apr 24 23:03:33 EDT 2025 Fri Nov 25 19:17:12 EST 2022 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 34 |
Keywords | Osteoporosis Primary biliary cirrhosis HCV infection |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c450t-d2bd89e454899f93cbe9428d1932c94037bdd15fa4f342e550e443daabb0a0f73 |
Notes | Osteoporosis Primary biliary cirrhosis Osteoporosis; Primary biliary cirrhosis; HCV infection HCV infection 14-1219/R R575.7 R681 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Correspondence to: Professor Annarosa Floreani, Div. Gastroenterologia, Via Giustiniani, 2, Padova 35128, Italy. annarosa.floreani@unipd.it Telephone: +39-49-8212894 Fax: +39-49-8760820 Author contributions: All authors contributed equally to the work. |
OpenAccessLink | https://www.wjgnet.com/1007-9327/full/v11/i34/5347.htm |
PMID | 16149144 |
PQID | 68562837 |
PQPubID | 23479 |
PageCount | 4 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4622807 wanfang_journals_wjg200534016 proquest_miscellaneous_68562837 pubmed_primary_16149144 crossref_primary_10_3748_wjg_v11_i34_5347 crossref_citationtrail_10_3748_wjg_v11_i34_5347 chongqing_backfile_20438662 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2005-09-14 |
PublicationDateYYYYMMDD | 2005-09-14 |
PublicationDate_xml | – month: 09 year: 2005 text: 2005-09-14 day: 14 |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | World journal of gastroenterology : WJG |
PublicationTitleAlternate | World Journal of Gastroenterology |
PublicationTitle_FL | WORLD JOURNAL OF GASTROENTEROLOGY |
PublicationYear | 2005 |
Publisher | Department of Surgical and Gastroenterological Sciences, University of Padova,Italy%Department of Medical and Surgical Sciences, University of Padova, Italy%Department of Public Health, University of Padova, Italy%Department of Clinical Chemistry, University of Padova, Italy Baishideng Publishing Group Inc |
Publisher_xml | – name: Department of Surgical and Gastroenterological Sciences, University of Padova,Italy%Department of Medical and Surgical Sciences, University of Padova, Italy%Department of Public Health, University of Padova, Italy%Department of Clinical Chemistry, University of Padova, Italy – name: Baishideng Publishing Group Inc |
References | ref13 ref12 ref15 ref14 ref20 ref11 ref22 ref10 ref21 ref2 ref1 ref17 ref16 ref19 ref18 ref8 ref7 ref9 ref4 ref3 ref6 ref5 |
References_xml | – ident: ref13 – ident: ref10 doi: 10.1053/jhep.2001.20533 – ident: ref6 – ident: ref22 doi: 10.1016/s0168-8278(01)81646-9 – ident: ref18 doi: 10.1016/S1297-319X(02)00364-0 – ident: ref11 doi: 10.1016/S0168-8278(99)80167-6 – ident: ref3 doi: 10.1016/S0168-8278(01)00144-1 – ident: ref2 doi: 10.1016/S0016-5085(03)01060-6 – ident: ref7 doi: 10.1159/000171456 – ident: ref9 doi: 10.1016/S0016-5085(00)70423-9 – ident: ref12 doi: 10.1136/gut.31.1.82 – ident: ref4 doi: 10.1002/lt.500040413 – ident: ref14 doi: 10.7326/0003-4819-103-6-855 – ident: ref15 doi: 10.1210/jcem-69-6-1234 – ident: ref5 doi: 10.1136/gut.49.2.282 – ident: ref20 doi: 10.1136/bmj.310.6991.1357 – ident: ref16 doi: 10.1172/JCI117959 – ident: ref8 doi: 10.1002/hep.1840210138 – ident: ref21 doi: 10.1002/jbmr.5650111203 – ident: ref1 doi: 10.1016/S0168-8278(03)00143-0 – ident: ref17 – ident: ref19 doi: 10.1016/S1590-8658(03)00078-1 |
SSID | ssj0023352 |
Score | 1.8689766 |
Snippet | AIM: (1) To compare the prevalence of osteoporosis (t-score ≤-2.5 SD) between stage IV PBC patients, and two groups of age- and sex-matched controls: one with... (1) To compare the prevalence of osteoporosis (t-score < or =-2.5 SD) between stage IV PBC patients, and two groups of age- and sex-matched controls: one with... R5; AIM: (1) To compare the prevalence of osteoporosis (t-score ≤-2.5 SD) between stage Ⅳ PBC patients, and two groups of age- and sex-matched controls: one... AIM: (1) To compare the prevalence of osteoporosis ( t -score ≤ -2.5 SD) between stage IV PBC patients, and two groups of age- and sex-matched controls: one... |
SourceID | pubmedcentral wanfang proquest pubmed crossref chongqing |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 5347 |
SubjectTerms | Adult Brief Reports Female Hepatitis C, Chronic - epidemiology Humans Liver Cirrhosis - epidemiology Liver Cirrhosis, Biliary - epidemiology Middle Aged Osteoporosis - epidemiology Prevalence Risk Factors 临床表现 原发性胆硬化 并发症 病理机制 骨质疏松症 |
Title | Is osteoporosis a peculiar association with primary biliary cirrhosis |
URI | http://lib.cqvip.com/qk/84123X/200534/20438662.html https://www.ncbi.nlm.nih.gov/pubmed/16149144 https://www.proquest.com/docview/68562837 https://d.wanfangdata.com.cn/periodical/wjg200534016 https://pubmed.ncbi.nlm.nih.gov/PMC4622807 |
Volume | 11 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELdgCIkXBOKrjEEeeEFVujS5fD0hhFa2aRsv7eibZTtO2zGSkXZM6l_PXeLmo0N8vaRV6jiuf2f77nz3M2NvA61AgFK2G0ttQwDSlkL5Ni6uMohwyQBNDv3Ts-BwAsdTf9ocb1Vml6zkQK1_mVfyP6jiPcSVsmT_Adm6UryB3xFfvCLCeP0rjI-WfcrRyFGHzolYRPSv6KzbhSj6oun2ytd6ZWglKBiWPtWiKOb01FZoXxVd0yKUmInlqsiJurOo-JrIifDl-FODfI6KZ3kyVJ_omLEp9VR_qo3flsImm5gg8S1fr8sHzgWteuYI78qjepmU3tvzBYpjts47bgmfYiiqdFAzk5IPFJXDsDPVDlsiZZyY1cTpexXx5vaMTuw4CMPNxWzwYzgcLDwYbIp2ybPPPvPR5OSEjw-m47vsnotWg7Nx3hj7m9LLys1v07Jq15resL9dPzFtzPNs9h31h67GcssMuR1Ne_9GZKnIZi1FZfyIPTQWhvWhEpfH7I7OnrDR0dJqi4olrI2oWC1RsUhULCMqlhEVqxaV90_ZZHQw_nhomyM0bAW-s7ITVyZRrAHt0jhOY09JHaPBmZDarmJwvFAmydBPBaQeuBrNVQ3gJUJI6QgnDb1nbCfLM_2CWeAmqSsSBVIApIJytNEWCAVWqPzIc3pst-4yVMHUVyIW45R6HQWB22P7m07kyrDP0yEolxytUIKAIwQcIeAIAScIeuxd_YT5378p-2aDC8fpkfa8RKbz6yUPIlTwIw9LPK9QaupCxTQeAvRY2MGvLkDE691fssW8JGCHoCSR6rE9gzQ3o3JJLaPR4AGaUi__2Kpd9qAZO6_Yzqq41nuo5K7k61J0fwLWNK3M |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Is+osteoporosis+a+peculiar+association+with+primary+biliary+cirrhosis%3F&rft.jtitle=World+journal+of+gastroenterology+%3A+WJG&rft.au=Floreani%2C+Annarosa&rft.au=Mega%2C+Andrea&rft.au=Camozzi%2C+Valentina&rft.au=Baldo%2C+Vincenzo&rft.date=2005-09-14&rft.issn=1007-9327&rft.volume=11&rft.issue=34&rft.spage=5347&rft_id=info:doi/10.3748%2Fwjg.v11.i34.5347&rft.externalDBID=NO_FULL_TEXT |
thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F84123X%2F84123X.jpg http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fwjg%2Fwjg.jpg |